NewsRoom Articles - Page 40 of 593

MondayJul 15, 2024 10:30 am

Golden Triangle Ventures Inc. (GTVH), Lavish Entertainment Report on Progress of One-of-a-Kind Entertainment Destination

New project “set to transform luxury entertainment and hospitality,” according to company officials Critical development has included work on infrastructure and improvements Officials also focused on obtaining required permits, assembling key leadership and identifying ideal vendors A luxury destination featuring world-class entertainment, opulent accommodations and immersive experiences is rising in the Mojave Desert. The unique property, called Destino Ranch, is a bold, visionary project envisioned by Golden Triangle Ventures (OTC: GTVH) and its wholly owned subsidiary, Lavish Entertainment. Golden Triangle and Lavish Entertainment recently provided an update (https://cnw.fm/Rfq7n) on the one-of-a-kind project, which is “set to transform luxury entertainment and hospitality.”…

MondayJul 15, 2024 10:00 am

Red Tape Continues to Hamper Marijuana Legalization Program in Germany

Earlier in the year, Germany became the first large nation in the European Union to legalize the personal recreational use of marijuana. In concrete terms, individuals aged 18 years and older are allowed to be in possession of no more than 25 grams of marijuana for consumption. Under the new law, enthusiasts can also grow three plants in their homes and store no more than 50 grams of dried marijuana in their homes. However, they aren’t allowed to smoke the drug in public. While this is a huge milestone, activists note that red tape has hindered the program from fully…

MondayJul 15, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Replicate Results from First GLP-1 Study Following CRO Contract Award for 12-Week Chronic Human Study

Lexaria, a global innovator in drug delivery platforms, recently hired a contract research organization (“CRO”) for its upcoming chronic human study, GLP-1-H24-4 This study will seek to evaluate various glucagon-like peptide-1 (“GLP-1”) formulations, processed with the company’s patented DehydraTECH(TM) technology The study will feature five arms, with each conducted using several investigational sites in Australia Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced the hiring of a contract research organization (“CRO”) that will be responsible for overseeing the execution of the company’s upcoming chronic human study, GLP-1-H24-4. This 12-week study will seek to evaluate various…

FridayJul 12, 2024 4:20 pm

420 with CNW — Maryland Celebrates a Year of Adult-Use Cannabis, Pardons and Massive Growth Realized

Maryland saw a windfall of more than $14 million from cannabis sales taxes in just the first quarter of this year. As the state celebrates the first anniversary of legal recreational cannabis, sales continue to climb. Connor Whelton, ReLeaf CEO and cofounder, says business is thriving in this environment. He and his team have introduced creative ways to serve their customers. From home-delivery services to a walk-up window and an inviting in-store menu, the Maryland-based company made accessibility a priority. Whelton says he notices a shift in his clientele as the negative perceptions of marijuana diminish. With recreational cannabis now…

FridayJul 12, 2024 10:00 am

Thai Marijuana Advocates Protest Plans to Outlaw Substance Again

In June 2022, Thailand made the decision to decriminalize marijuana, making it the first country in southeast Asia to do so. The campaign to decriminalize the drug was spearheaded by Anutin Charnvirakul of the Bhumjaithai Party. Anutin, who headed the Ministry of Health in 2022, called for an amendment to be made to the Narcotics Law. This subsequently led to marijuana being eliminated from Thailand’s list of controlled substances. While the drug was intended solely for medicinal use with the law also allowing private recreational use, the market remained unregulated. This allowed recreational use to flourish but increased public concerns…

FridayJul 12, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Dedicated to Creating Unparalleled Tech, Labs, Facilities and Teams in Cannabis Space

MedCana offers a long list of proprietary essential services to its clients The company’s team of pharmaceutical scientists includes some of the world’s most respected chemists From initial grow to final product, MedCana helps partners produce pharmaceutical CBD and other extracts that have no equal As the cannabis industry prepares to enter a new era with a pending schedule change in the Controlled Substances Act (“CSA”), Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is committed to being a worldwide force for high-quality cannabis products. To achieve this lofty goal, the company is focused on building the technology, laboratories, growing facilities,…

ThursdayJul 11, 2024 4:20 pm

420 with CNW — Florida’s Marijuana Legalization Ballot Measure Could Face Heavily Funded Opposition

The recreational cannabis legalization campaign in Florida is up against a significant new challenge: heavily funded opposition. Florida Governor Ron DeSantis (R) recently created the Florida Freedom Fund, allowing him to receive unlimited donations aimed at achieving the fund’s specific goals. A primary objective of the fund is to thwart Amendment 3, which proposes to legalize recreational marijuana and permit sales at already-existing medical cannabis dispensaries. In the unlikely event that DeSantis is successful in garnering national attention and support for this cause, the legalization of recreational marijuana may not be supported by a larger financial advantage throughout its campaign.…

WednesdayJul 10, 2024 4:20 pm

420 with CNW — Kentucky to Start Receiving Applications from Medical Marijuana Companies

Businesses in Kentucky looking to grow, process or sell medical cannabis can start submitting applications for licenses on Monday, July 1, 2024. Governor Andy Beshear announced this as part of an expedited effort to have products on the market by early 2025. Healthcare providers, including advanced-practice registered nurses and doctors, can also start applying to certify qualified patients for purchasing medical cannabis. The process will be overseen by the state’s Board of Medical Licensure and Board of Nursing. The state’s medical marijuana program is officially scheduled to kick off on Jan. 1, 2025. The legislation, passed in 2023 with bipartisan…

WednesdayJul 10, 2024 10:00 am

Social Workers Urge Biden to Decriminalize Rather Than Just Reclassify Marijuana

Social workers are pushing for President Joe Biden to fully eliminate marijuana from the Controlled Substances Act (CSA), arguing that there is a need for the drug’s decriminalization. This comes even after the White House proposed that the drug be downgraded to Schedule 3 from Schedule 1. In a letter penned to Biden, 148 social workers explained that cannabis criminalization had torn apart families, mainly affecting communities of color. They called attention to the fact that their profession allowed them to witness the serious harm that cannabis criminalization had caused, adding that cannabis remaining under the CSA would ensure suffering…

WednesdayJul 10, 2024 9:45 am

The 5th Annual NECANN New Jersey Cannabis Convention Projected to Witness Mammoth Turnout

The NECANN New Jersey Cannabis Convention will be held in partnership with 420NJevents at the Atlantic City Convention Center, September 6-7. As the NECANN family continues to grow every year, the turnout this year is expected to cross 4,000+ attendees with 200 exhibitors showcasing their innovative business ideas. The NECANN New Jersey Cannabis Convention has developed robust networking and business connections since its first event in 2019. The convention will be attended by influential canna traders, license holders, dispensary owners, suppliers, investors, ancillary industries, and industry leaders from the East Coast and beyond. New Jersey has a thriving cannabis market,…

News and publishing service for cannabis related companies

Contact us: 512.354.7000